0.9469
Tenaya Therapeutics Inc Aktie (TNYA) Neueste Nachrichten
Tenaya Therapeutics announces securities offering - Investing.com India
Tenaya Therapeutics Announces Proposed Offering of Common Stock and Warrants - Nasdaq
Tenaya Therapeutics Announces Proposed Public Offering - GlobeNewswire
Heart Disease Biotech Tenaya Seeks Fresh Capital Through Complex Warrant Offering - StockTitan
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences - The Manila Times
Can Tenaya's Heart Disease Therapies Impress Investors at March Conferences? - StockTitan
H.C. Wainwright maintains buy rating on Tenaya Therapeutics stock - MSN
Monitoring Tenaya Therapeutics Inc (TNYA) after recent insider movements - Knox Daily
Head to Head Survey: Tenaya Therapeutics (NASDAQ:TNYA) and PharmaCyte Biotech (OTCMKTS:PMCBD) - Defense World
Taking on analysts’ expectations and winning: Tenaya Therapeutics Inc (TNYA) - SETE News
SG Americas Securities LLC Purchases 15,777 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
It is Poised to be a Bull Market for Tenaya Therapeutics Inc (TNYA) - SETE News
Technical analysis of Tenaya Therapeutics Inc (TNYA) stock chart patterns - US Post News
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Tenaya Therapeutics appoints new interim principal accounting officer - MSN
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Target Price at $17.33 - Defense World
Tenaya Therapeutics appoints new interim principal accounting officer By Investing.com - Investing.com Canada
Tenaya Therapeutics Appoints Interim Accounting Officer - TipRanks
Tenaya Therapeutics Inc (TNYA) Stock: A Year of Market Fluctuations - The InvestChronicle
BlackRock, Inc. Acquires Additional Shares in Tenaya Therapeutics Inc - GuruFocus.com
A History of Outperforming Analyst Forecasts and Beating the Odds: Tenaya Therapeutics Inc (TNYA) - SETE News
Tenaya Therapeutics (NASDAQ:TNYA) Earns "Buy" Rating from HC Wainwright - MarketBeat
Recent Insider Activity Suggests Potential Gains for Tenaya Therapeutics Inc (TNYA) - Knox Daily
Tenaya Therapeutics (NASDAQ:TNYA) Earns “Buy” Rating from HC Wainwright - Defense World
Analyze Tenaya Therapeutics Inc (NASDAQ: TNYA) Before Investing. - Stocks Register
Market Watch Highlights: Tenaya Therapeutics Inc (TNYA) Ends on an Downturn Note at 1.05 - The Dwinnex
Is Tenaya Therapeutics Inc (TNYA) a good investment opportunity? - US Post News
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine - GlobeNewswire
TNYATenaya Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Tenaya Therapeutics receives $8M clinical grant from CIRM - MSN
Promising Potential of Tenaya Therapeutics: Buy Rating Justified by Financial Backing and Clinical Progress - TipRanks
Major Funding Breakthrough: Rare Heart Disease Gene Therapy Trial Gets $8M Boost - StockTitan
Tenaya Therapeutics announces option repricing to retain staff - MSN
Tenaya Therapeutics announces option repricing to retain staff By Investing.com - Investing.com Australia
Tenaya Therapeutics Reprices Underwater Stock Options - TipRanks
Here's Why Tenaya Therapeutics (NASDAQ:TNYA) Must Use Its Cash Wisely - Simply Wall St
Tenaya Therapeutics (TNYA) Stock Price, News & Analysis - MarketBeat
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Shares Sold by Jane Street Group LLC - Defense World
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $17.33 Average PT from Brokerages - MarketBeat
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) PT at $17.33 - Defense World
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Short Interest Update - MarketBeat
HC Wainwright Reiterates Buy Rating for Tenaya Therapeutics (NASDAQ:TNYA) - MarketBeat
Tenaya advances gene therapies for heart conditions By Investing.com - Investing.com Canada
Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones - GlobeNewswire
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):